BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson K, Haas DM, Plante L, Metz T, Casey B, Esplin S, Longo S, Hoffman M, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su E, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Geller NL, Oparil S, Cutter GR, Andrews WW; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med 2022;386:1781-92. [PMID: 35363951 DOI: 10.1056/NEJMoa2201295] [Cited by in Crossref: 39] [Cited by in F6Publishing: 48] [Article Influence: 39.0] [Reference Citation Analysis]
Number Citing Articles
1 Gupta S, Petras L, Tufail MU, Rodriguez Salazar JD, Jim B. Hypertension in Pregnancy: What We Now Know. Curr Opin Nephrol Hypertens 2023;32:153-64. [PMID: 36683540 DOI: 10.1097/MNH.0000000000000857] [Reference Citation Analysis]
2 Sanusi AA, Sinkey RG. De Novo Postpartum Hypertension: Is Pregnancy a Stress Test or Risk Factor? Hypertension 2023;80:288-90. [PMID: 36652531 DOI: 10.1161/HYPERTENSIONAHA.122.20155] [Reference Citation Analysis]
3 D'Ignazio T, Grand'Maison S, Bérubé L, Forcillo J, Pacheco C. Hypertension across a Woman's lifespan. Maturitas 2023;168:84-91. [PMID: 36549261 DOI: 10.1016/j.maturitas.2022.11.006] [Reference Citation Analysis]
4 Cleary EM, Racchi NW, Patton KG, Kudrimoti M, Costantine MM, Rood KM. Trial of Intrapartum Extended-Release Nifedipine to Prevent Severe Hypertension Among Pregnant Individuals With Preeclampsia With Severe Features. Hypertension 2023;80:335-42. [PMID: 36189646 DOI: 10.1161/HYPERTENSIONAHA.122.19751] [Reference Citation Analysis]
5 Fakhouri F, Schwotzer N, Cabiddu G, Barratt J, Legardeur H, Garovic V, Orozco-Guillen A, Wetzels J, Daugas E, Moroni G, Noris M, Audard V, Praga M, Llurba E, Wuerzner G, Attini R, Desseauve D, Zakharova E, Luders C, Wiles K, Leone F, Jesudason S, Costedoat-Chalumeau N, Kattah A, Soto-Abraham V, Karras A, Prakash J, Lightstone L, Ronco P, Ponticelli C, Appel G, Remuzzi G, Tsatsaris V, Piccoli GB. Glomerular diseases in pregnancy: pragmatic recommendations for clinical management. Kidney Int 2023;103:264-81. [PMID: 36481180 DOI: 10.1016/j.kint.2022.10.029] [Reference Citation Analysis]
6 Bublitz MH, Salmoirago-Blotcher E, Sanapo L, Ayala N, Mehta N, Bourjeily G. Feasibility, acceptability, and preliminary effects of mindfulness training on antenatal blood pressure. J Psychosom Res 2023;165:111146. [PMID: 36621212 DOI: 10.1016/j.jpsychores.2023.111146] [Reference Citation Analysis]
7 Fishel Bartal M, Chen HY, Amro F, Mendez-Figueroa H, Wagner SM, Sibai BM, Chauhan SP. Racial and Ethnic Disparities among Pregnancies with Chronic Hypertension and Adverse Outcomes. Am J Perinatol 2023. [PMID: 36528021 DOI: 10.1055/a-2000-6289] [Reference Citation Analysis]
8 Bager JE, Manhem K, Andersson T, Hjerpe P, Bengtsson-Boström K, Ljungman C, Mourtzinis G. Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care. J Hum Hypertens 2023. [PMID: 36658330 DOI: 10.1038/s41371-023-00801-5] [Reference Citation Analysis]
9 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Das SR, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Kosiborod M, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023. Diabetes Care 2023;46:S158-90. [PMID: 36507632 DOI: 10.2337/dc23-S010] [Reference Citation Analysis]
10 You WB, Thomas J. How High Is Too High: Implications of Hypertension on the Fetus and Neonate. Neoreviews 2023;24:43-6. [PMID: 36587008 DOI: 10.1542/neo.24-1-e43] [Reference Citation Analysis]
11 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Jeffrie Seley J, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023. Diabetes Care 2023;46:S254-66. [PMID: 36507645 DOI: 10.2337/dc23-S015] [Reference Citation Analysis]
12 Nurkkala J, Kauko A, Finngen, Laivuori H, Saarela T, Tyrmi JS, Vaura F, Cheng S, Bello NA, Aittokallio J, Niiranen T. Associations of polygenic risk scores for preeclampsia and blood pressure with hypertensive disorders of pregnancy. Journal of Hypertension 2022;Publish Ahead of Print. [DOI: 10.1097/hjh.0000000000003336] [Reference Citation Analysis]
13 Chen Z, Wang J, Carru C, Chen Y, Li Z. Treatment for mild hypertension in pregnancy with different strategies: A systematic review and meta-analysis. Int J Gynaecol Obstet 2022. [PMID: 36528834 DOI: 10.1002/ijgo.14634] [Reference Citation Analysis]
14 Palatnik A, Mukhtarova N, Hetzel SJ, Hoppe KK. Blood pressure changes in gestational hypertension, preeclampsia, and chronic hypertension from preconception to 42-day postpartum. Pregnancy Hypertension 2023;31:25-31. [DOI: 10.1016/j.preghy.2022.11.009] [Reference Citation Analysis]
15 Obara T, Ishikuro M, Ueno F, Noda A, Murakami K, Kuriyama S. Antihypertensive drug use during pregnancy in Japan. Hypertens Res 2022. [DOI: 10.1038/s41440-022-01101-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chronische Hypertonie in der Schwangerschaft: Therapie bereits ab 140/90 mmHg? Kardiologie up2date 2022;18:311-312. [DOI: 10.1055/a-1958-8441] [Reference Citation Analysis]
17 Aderibigbe OA, Hackney DN, Ranzini AC, Lappen JR. Tight vs liberal control of mild postpartum hypertension: a randomized controlled trial. Am J Obstet Gynecol MFM 2022;5:100818. [PMID: 36402355 DOI: 10.1016/j.ajogmf.2022.100818] [Reference Citation Analysis]
18 Bontsevich RA, Balamutova TI, Chukhareva NA, Tsygankova OV, Batisheva GA, Paleskava A, Kompaniets OG, Ketova GG, Barysheva VO, Nevzorova VA, Martynenko IM, Pakhomov SP. Physicians’ knowledge and preferences in tactics of management and rational pharmacotherapy of arterial hypertension in pregnant women (PHYGEST study). RRP 2022;8:57-64. [DOI: 10.3897/rrpharmacology.8.80759] [Reference Citation Analysis]
19 Thadhani R, Lemoine E, Rana S, Costantine MM, Calsavara VF, Boggess K, Wylie BJ, Moore Simas TA, Louis JM, Espinoza J, Gaw SL, Murtha A, Wiegand S, Gollin Y, Singh D, Silver RM, Durie DE, Panda B, Norwitz ER, Burd I, Plunkett B, Scott RK, Gaden A, Bautista M, Chang Y, Diniz MA, Karumanchi SA, Kilpatrick S. Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy. NEJM Evidence 2022. [DOI: 10.1056/evidoa2200161] [Reference Citation Analysis]
20 Chung K, Yin O, Kallapur A, Bass L, Coscia L, Constantinescu S, Moritz M, Afshar Y. Emergent prelabor cesarean delivery in solid organ transplant recipients: associated risk factors and outcomes. Am J Obstet Gynecol MFM 2022;5:100799. [PMID: 36368514 DOI: 10.1016/j.ajogmf.2022.100799] [Reference Citation Analysis]
21 Bernstein SL. New Management Guidelines for Mild Hypertension During Pregnancy. MCN: The American Journal of Maternal/Child Nursing 2022;47:359-359. [DOI: 10.1097/nmc.0000000000000857] [Reference Citation Analysis]
22 Fernández Olmo MR, Cordero Fort A, Torres Llergo J, Marzal Martín D, Baquero Alonso M, Martínez Quesada M, Palau Sampio P, Campuzano Ruiz R. Selección de lo mejor del año en 2022 en riesgo vascular y rehabilitación cardiaca. REC: CardioClinics 2022. [DOI: 10.1016/j.rccl.2022.10.002] [Reference Citation Analysis]
23 Wilkie G, Skaritanov E, Tobin M, Essa A, Gubala A, Ferraro L, Kovell LC. Hypertension in Women: Impact of Contraception, Fertility, and Hormone Treatment. Curr Cardiovasc Risk Rep 2022. [DOI: 10.1007/s12170-022-00705-y] [Reference Citation Analysis]
24 Bane S, Wall-Wieler E, Druzin ML, Carmichael SL. Antihypertensive Medication Use before and during Pregnancy and the Risk of Severe Maternal Morbidity in Individuals with Prepregnancy Hypertension. Am J Perinatol 2022. [PMID: 36261063 DOI: 10.1055/s-0042-1757354] [Reference Citation Analysis]
25 Thomopoulos C, Ilias I. Are pregnancy-associated hypertensive disorders so sweet? World J Clin Cases 2022; 10(28): 10384-10386 [DOI: 10.12998/wjcc.v10.i28.10384] [Reference Citation Analysis]
26 Leeson P. Chronic Hypertension in Pregnancy Project and the Control of Hypertension in Pregnancy Study: impact of blood pressure control in pregnancy on maternal and fetal outcomes. Cardiovasc Res 2022:cvac147. [PMID: 36196605 DOI: 10.1093/cvr/cvac147] [Reference Citation Analysis]
27 Khan SS, Yee LM. Not-So-Mild Consequences of Mild Hypertension in Pregnancy. Obstet Gynecol 2022;140:543-5. [PMID: 36075078 DOI: 10.1097/AOG.0000000000004945] [Reference Citation Analysis]
28 Briller JE. Echocardiographic Screening in Hypertensive Pregnancy Disorders. Journal of the American College of Cardiology 2022;80:1477-1479. [DOI: 10.1016/j.jacc.2022.08.717] [Reference Citation Analysis]
29 Legro RS. Periconception care of the infertile patient: Are we doing enough? Fertil Steril 2022;118:653-5. [PMID: 36182262 DOI: 10.1016/j.fertnstert.2022.08.018] [Reference Citation Analysis]
30 Fry ETA, Wood MJ, Walsh MN. Maternal Health: The Heart of the Matter. J Am Coll Cardiol 2022;80:1107-9. [PMID: 36075681 DOI: 10.1016/j.jacc.2022.08.001] [Reference Citation Analysis]
31 . Treatment of chronic mild hypertension in pregnancy. DTB 2022. [DOI: 10.1136/dtb.2022.000049] [Reference Citation Analysis]
32 Sanga V, Rossitto G, Seccia TM, Rossi GP. Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review. Hypertension 2022;79:1912-21. [PMID: 35686552 DOI: 10.1161/HYPERTENSIONAHA.121.18858] [Reference Citation Analysis]
33 Wautlet CK, Hoffman MC. Hypertensive Crisis in Pregnancy. Obstet Gynecol Clin North Am 2022;49:501-19. [PMID: 36122982 DOI: 10.1016/j.ogc.2022.02.016] [Reference Citation Analysis]
34 . Chronische Hypertonie in der Schwangerschaft: Therapie bereits ab 140/90 mmHg. Dtsch Med Wochenschr 2022;147:1168-1168. [DOI: 10.1055/a-1871-4430] [Reference Citation Analysis]
35 Magee LA, von Dadelszen P. Hypertension in Pregnancy. nephsap 2022;21:311-322. [DOI: 10.1681/nsap.00092022] [Reference Citation Analysis]
36 Varner CE, Park AL, Ray JG. Prepregnancy Emergency Department Use and Risks of Severe Maternal and Neonatal Morbidity in Canada. JAMA Netw Open 2022;5:e2229532. [PMID: 36053536 DOI: 10.1001/jamanetworkopen.2022.29532] [Reference Citation Analysis]
37 Federle L. Part II : Interactive case: Cardiovascular diseases in pregnancy. J Am Coll Clin Pharm 2022;5:1016-1020. [DOI: 10.1002/jac5.1689] [Reference Citation Analysis]
38 Cífková R, Strilchuk L. Sex differences in hypertension. Do we need a sex-specific guideline? Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.960336] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Cozzi GD, Jauk VC, Szychowski JM, Tita AT, Battarbee AN, Subramaniam A. Participation in obstetrical studies is associated with improved pregnancy outcomes. Am J Obstet Gynecol MFM 2022;4:100729. [PMID: 35995368 DOI: 10.1016/j.ajogmf.2022.100729] [Reference Citation Analysis]
40 . Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med 2022;387:663-4. [DOI: 10.1056/nejmc2207889] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Wells CE, Cunningham FG. Treatment of Chronic Hypertension in Pregnancy: Is It Time for a Change? Circulation 2022;146:433-4. [PMID: 35939547 DOI: 10.1161/CIRCULATIONAHA.122.060548] [Reference Citation Analysis]
42 Metcalfe RK, Harrison M, Singer J, Lewisch M, Lee T, von Dadelszen P, Magee LA, Bansback N. Using a Patient-Centered Composite Endpoint in a Secondary Analysis of the Control of Hypertension in Pregnancy Study (CHIPS) Trial.. [DOI: 10.21203/rs.3.rs-1909786/v1] [Reference Citation Analysis]
43 Lanthier L, Sauvé N, Plourde MÉ, Cauchon M. [In pregnant women with mild chronic hypertension, does a treatment strategy using a treatment target<140/90mmHg compared to watchful waiting unless BP>160/105mmHg reduce the incidence of maternal and perinatal complications while being safe?]. Rev Med Interne 2022;43:514-5. [PMID: 35868989 DOI: 10.1016/j.revmed.2022.07.003] [Reference Citation Analysis]
44 Rismiati H, Lee H. Blood pressure control in hypertensive disorders of pregnancy. CPP 2022;4:99-105. [DOI: 10.36011/cpp.2022.4.e16] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Bond RM, Phillips K, Ivy KN, Ogueri V, Parapid B, Miller SC, Ansong A. Cardiovascular Health of Black Women Before, During, and After Pregnancy: A Call to Action and Implications for Prevention. Curr Cardiovasc Risk Rep. [DOI: 10.1007/s12170-022-00703-0] [Reference Citation Analysis]
46 Mogi M, Maruhashi T, Higashi Y, Masuda T, Nagata D, Nagai M, Bokuda K, Ichihara A, Nozato Y, Toba A, Narita K, Hoshide S, Tanaka A, Node K, Yoshida Y, Shibata H, Katsurada K, Kuwabara M, Kodama T, Shinohara K, Kario K. Update on Hypertension Research in 2021. Hypertens Res 2022. [PMID: 35790879 DOI: 10.1038/s41440-022-00967-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Do NC, Vestgaard M, Ásbjörnsdóttir B, Andersen LLT, Jensen DM, Ringholm L, Damm P, Mathiesen ER. Home blood pressure for the prediction of preeclampsia in women with pre-existing diabetes. J Clin Endocrinol Metab 2022:dgac392. [PMID: 35766641 DOI: 10.1210/clinem/dgac392] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Kurhade C, Zou J, Xia H, Cai H, Yang Q, Cutler M, Cooper D, Muik A, Jansen KU, Xie X, Swanson KA, Shi PY. Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine. Nat Commun 2022;13:3602. [PMID: 35739094 DOI: 10.1038/s41467-022-30681-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
49 Kikuchi D, Obara T, Miura R, Suzuki N, Hirakawa H, Josaka R, Ito M, Tokunaga M, Usui K, Okada K. Antihypertensive drug prescription trends for pregnant women with hypertension in acute hospitals in Japan. Hypertens Res 2022. [PMID: 35715513 DOI: 10.1038/s41440-022-00956-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Tita A, Giles R. Treating chronic mild hypertension during pregnancy leads to better outcomes. Medicom Conference Report ACC 2022 2022. [DOI: 10.55788/f538e95e] [Reference Citation Analysis]
51 Cameron NA, Bello NA, Khan SS. Bringing the cuff home: Challenges and opportunities associated with home blood pressure monitoring among reproductive aged individuals. Am J Hypertens 2022:hpac074. [PMID: 35695260 DOI: 10.1093/ajh/hpac074] [Reference Citation Analysis]
52 Laura L, Dalmatin-Dragišić M, Martinović K, Tutiš B, Herceg I, Arapović M, Arapović J. Does pre-existing immunity determine the course of SARS-CoV-2 infection in health-care workers? Single-center experience. Infection 2022. [PMID: 35696057 DOI: 10.1007/s15010-022-01859-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Thomopoulos C, Brguljan J, Cífková R, Persu A, Kreutz R. Mild chronic hypertension in pregnancy: to treat or wait? Blood Pressure 2022;31:121-4. [DOI: 10.1080/08037051.2022.2077698] [Reference Citation Analysis]
54 . Chronische Hypertonie in der Schwangerschaft: Therapie bereits ab 140/90 mmHg? Z Geburtshilfe Neonatol 2022;226:155-155. [DOI: 10.1055/a-1819-8067] [Reference Citation Analysis]
55 Sharma G, Grobman WA, Khan SS. Blood Pressure Management in Pregnancy. JACC: Advances 2022;1:100037. [DOI: 10.1016/j.jacadv.2022.100037] [Reference Citation Analysis]
56 Hermel M, Tsai S, Dlouhy L, B K A, Rana JS, Dani SS, Virani SS. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions. Curr Atheroscler Rep 2022. [PMID: 35633463 DOI: 10.1007/s11883-022-01042-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Zou J, Kurhade C, Xia H, Liu M, Xie X, Ren P, Shi PY. Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2. Nat Commun 2022;13:2956. [PMID: 35618703 DOI: 10.1038/s41467-022-30580-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
58 Charonis SA, James LM, Georgopoulos AP. SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC). Sci Rep 2022;12:8074. [PMID: 35577837 DOI: 10.1038/s41598-022-11956-5] [Reference Citation Analysis]
59 Galiuto L, Volpe M. Treatment of mild hypertension improves pregnancy outcomes. Eur Heart J 2022:ehac255. [PMID: 35551381 DOI: 10.1093/eurheartj/ehac255] [Reference Citation Analysis]
60 Berec L, Levínský R, Weiner J, Šmíd M, Neruda R, Vidnerová P, Suchopárová G. Importance of vaccine action and availability and epidemic severity for delaying the second vaccine dose. Sci Rep 2022;12:7638. [PMID: 35538118 DOI: 10.1038/s41598-022-11250-4] [Reference Citation Analysis]
61 Thakkar A, Hailu T, Blumenthal RS, Martin SS, Harrington CM, Yeh DD, French KA, Sharma G. Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention. Curr Atheroscler Rep 2022. [PMID: 35524915 DOI: 10.1007/s11883-022-01026-6] [Reference Citation Analysis]
62 Chandrasekaran S, Badell ML, Jamieson DJ. Management of Chronic Hypertension During Pregnancy. JAMA 2022;327:1700-1. [PMID: 35503360 DOI: 10.1001/jama.2022.3919] [Reference Citation Analysis]
63 Carney EF. Treating mild chronic hypertension in pregnancy. Nat Rev Nephrol 2022. [PMID: 35484396 DOI: 10.1038/s41581-022-00578-9] [Reference Citation Analysis]
64 Huynh K. Treatment of mild chronic hypertension in pregnancy reduces pre-eclampsia risk. Nat Rev Cardiol 2022. [PMID: 35444298 DOI: 10.1038/s41569-022-00712-x] [Reference Citation Analysis]
65 . Ambitious trial inspires a rethink on a common ailment of pregnancy. Nature 2022. [PMID: 35393588 DOI: 10.1038/d41586-022-00981-z] [Reference Citation Analysis]
66 Choi E, Kazzi B, Varma B, Ortengren AR, Minhas AS, Vaught AJ, Bennett WL, Lewey J, Michos ED. The Fourth Trimester: a Time for Enhancing Transitions in Cardiovascular Care. Curr Cardiovasc Risk Rep 2022;16:219-29. [PMID: 36159207 DOI: 10.1007/s12170-022-00706-x] [Reference Citation Analysis]